Skip to main content
Eterna Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.250
+0.003 (1.05%)
At close: Dec 20, 2024, 4:00 PM
0.257
+0.006 (2.56%)
After-hours: Dec 20, 2024, 6:58 PM EST

Eterna Therapeutics Revenue

Eterna Therapeutics had revenue of $487.00K in the quarter ending September 30, 2024, with 854.90% growth. This brings the company's revenue in the last twelve months to $598.00K, up 1,072.55% year-over-year. In the year 2023, Eterna Therapeutics had annual revenue of $68.00K.

Revenue (ttm)
$598.00K
Revenue Growth
+1,072.55%
P/S Ratio
2.26
Revenue / Employee
$74,750
Employees
8
Market Cap
12.85M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202368.00K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cosmos Health 56.04M
Marinus Pharmaceuticals 31.47M
Lifeward 25.00M
Ekso Bionics Holdings 17.68M
Aspira Women's Health 8.96M
Kazia Therapeutics 1.66M
TherapeuticsMD 1.60M
Revenue Rankings

ERNA News

More News